Treace to Announce Interim Results from ALIGN3D™ at ACFAS 2021
May 12 2021 - 8:00AM
Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a
commercial-stage orthopaedic medical device company driving a
paradigm shift in the surgical treatment of Hallux Valgus (commonly
known as bunions), today announced that interim results from its
ALIGN3D™ clinical study will be presented at the upcoming American
College of Foot and Ankle Surgeons (ACFAS) Scientific Conference.
On May 19, 2021 at the Latest in Foot Surgery
Session, the Interim Analysis of a Five-Year Prospective
Multicenter Study Assessing Radiographic and Patient Reported
Outcomes Following Triplanar Tarsometatarsal Arthrodesis with Early
Weightbearing, will be presented by Dr. George T. Liu of UT
Southwestern Medical Center.
About the ALIGN3D Clinical Study
The ALIGN3D™ clinical study is a prospective,
multicenter, post-market study designed to evaluate outcomes of
Lapiplasty® 3D Bunion Correction™ in the surgical management of
symptomatic hallux valgus. The study will evaluate for consistent
and reliable correction of all three dimensions of the bunion
deformity with the Lapiplasty® Procedure, as well as maintenance of
such correction following accelerated return to weight-bearing. The
primary effectiveness endpoint is radiographic recurrence of the
hallux valgus deformity at 24 months follow up. Key secondary
endpoints include change in three-dimensional radiographic
alignment; clinical radiographic healing; time to start of
weight-bearing in a boot and in shoes; pain; quality of life; and
range of motion of the big toe joint. The study enrolled 173
patients, aged 14 to 58 years, at 7 clinical sites in the United
States with 13 participating surgeons. Final patient follow-up for
the primary endpoint is anticipated in the first half of 2023.
About ACFAS Scientific Conference
The American College of Foot and Ankle Surgeons
(ACFAS) is a professional society of more than 7,800 foot and ankle
surgeons. The annual ACFAS Scientific Conference is an educational
event gathering foot and ankle surgeons worldwide.
About Treace Medical Concepts
Treace Medical Concepts is a commercial-stage
orthopaedic medical device company with the goal of advancing the
standard of care for the surgical management of bunion deformities.
Bunions are complex 3-dimensional deformities that originate from
an unstable joint in the middle of the foot. Treace has pioneered
and patented the Lapiplasty® 3D Bunion Correction™ system - a
combination of instruments, implants, and surgical methods designed
to correct all 3 planes of the bunion deformity and secure the
unstable joint, addressing the root cause of the bunion and getting
patients back to their active lives quickly.
To learn more about Lapiplasty® 3D Bunion
Correction™, or find a Lapiplasty® surgeon in your area, please
visit: www.AlignMyToe.com or www.treace.com/patients.
Contacts:Treace Medical
ConceptsMark L. HairChief Financial
Officermhair@treace.net(904) 373-5940
Investors:Gilmartin GroupLynn
Lewis or Vivian CervantesIR@treace.net
Treace Medical Concepts (NASDAQ:TMCI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Treace Medical Concepts (NASDAQ:TMCI)
Historical Stock Chart
From Apr 2023 to Apr 2024